Because type 1 diabetes can be very difficult to effectively manage in children and adolescents, these study investigators compared outcomes between a hybrid closed-loop algorithm add-on and usual ...

Please provide your email address to receive an email when new articles are posted on . Implicity announced the FDA cleared its algorithm analyzing ECG data from implantable loop recorders.

The possible advantage of hybrid closed-loop therapy (i.e., artificial pancreas) over sensor-augmented pump therapy in very young children with type 1 diabetes is unclear. In this multicenter, ...

The US Food and Drug Administration (FDA) has cleared the Tidepool Loop, a mobile application for use with compatible continuous glucose monitors (CGMs) and insulin pumps to enable automated insulin ...

While insulin pumps and continuous glucose monitors have improved the lives of many Type 1 diabetes patients, some still cannot maintain steady control. Implantable insulin pumps offer another option ...